![1-(4-Methoxyphenyl)-7-oxo{-6-[4-({2-oxopiperidin{-1-il)phenyl]{{7} Trab](/uploads/32977/sponge-microneedle88318.png?size=398x0)
![1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid Ethyl Ester CAS 503614-91-3 Powder](/uploads/32977/sponge-microneedle88318.png)
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid Ethyl Ester CAS 503614-91-3 Powder
![1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid Ethyl Ester CAS 503614-91-3 Powder](/uploads/32977/1-4-methoxyphenyl-7-oxo-6-4-2-oxopiperidin7425f.jpg)
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid Ethyl Ester CAS 503614-91-3 Powder
![1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid Ethyl Ester CAS 503614-91-3 Powder](/uploads/32977/1-4-methoxyphenyl-7-oxo-6-4-2-oxopiperidind0a86.jpg)
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid Ethyl Ester CAS 503614-91-3 Powder
![1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid Ethyl Ester CAS 503614-91-3 Powder](/uploads/32977/1-4-methoxyphenyl-7-oxo-6-4-2-oxopiperidin24d5f.jpg)
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid Ethyl Ester CAS 503614-91-3 Powder
1-(4-Methoxyphenyl)-7-oxo{-6-[4-({2-oxopiperidin{-1-il)phenyl]{{7} Trab
CAS:503614-91-3
MF:C25H25N5O4
Purità: 99% min
Max impurità waħda: Inqas minn jew ugwali għal 0.1%
Kapaċità: 1000kg/M
Qasam ta' Terapija: Kardjovaskulari
Dokumentazzjoni VQ u verifika tas-sit: Disponibbli
Deskrizzjoni
Introduzzjoni
1-(4-Methoxyphenyl)-7-oxo{-6-[4-({2-oxopiperidin{-1-il)phenyl]{{7} },5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester huwa intermedju għall-preparazzjoni ta' apixaban.
Speċifikazzjoni tas-CAS 503614-91-3|1-(4-Methoxyphenyl)-7-oxo-6-[4-({2-oxopiperidin{-1-il)phenyl]{{8} },5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester (Ara COA-PDF).
| 1-(4-Methoxyphenyl)-7-oxo{-6-[4-({2-oxopiperidin{-1-il)phenyl]{{7} },5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester | 503614-91-3 | Apixaban intermedju | ||||
| Aċidu aċetiku, 2-kloro-2-[2-({4-methoxyphenyl)hydrazinylidene], ethyl ester | 27143-07-3 | Apixaban intermedju | ||||
| 2(1H)-piridina,3-kloro-5,6-diidro-1-(4-nitrofenil) | 536760-29-9 | Apixaban intermedju | ||||
| 3-Morpholin-4-il-1-[4-(2-oxopiperidin{-1-il)fenil]-5,6- diidro-1H-piridin-2-wieħed | 545445-44-1 | Apixaban intermedju | ||||
| 3-(4-Morfolinil)-1-(4-nitrofenil)-5,6-diidro-2(1H)-piridinon | 503615-03-0 | Apixaban intermedju | ||||
| Etil 1-(4-metossifenil)-6-(4-nitrofenil)-7-oxo-4,5,6,7-tetraidro{ {9}}H-pyrazolo[3,4-c]piridina-3 | 536759-91-8 | Apixaban intermedju | ||||
| etil 6-(4-aMinophenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetraidro{ {9}}H-pyrazolo[3,4-c]piridina-3-carboxylate | 503615-07-4 | Apixaban intermedju | ||||
| 1-(4-AMinofenil)-5,6-diidro-3-(4-Morfolinil)-2(1h)-piridinon | 1267610-26-3 | Apixaban intermedju | ||||
| (2Z)-kloro[(4-metossifenil)idrazono]etanoat tal-etil | 473927-63-8 | Apixaban intermedju | ||||
Kun af aktar, jekk jogħġbok tħossok liberu li tilħaqsales02@pharmachemm.com (Miss Ada Li).
Merħba iżżurna fuq
CPHI Ewropa 2024Kabina 1A138-7Ottubru 8-10 Milan l-Italja
Pharmtech & Ingredjenti 2024Booth CCC-76Nov 19-22 Moska Russja.
It-tags Popolari: 1-(4-metossifenil)-7-oxo-6-[4-({2-oxopiperidin{-1-il)fenil]{{7} },5,6,7-tetrahydro-1h-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester cas 503614-91-3 trab, iċ-Ċina, fornituri, manifatturi, fabbrika, bl-ingrossa, jixtru, bl-ingrossa, prezz, għall-bejgħ, fl-istokk
Ibgħat l-inkjesta
Tista 'Tħobb ukoll
